Aptose Biosciences
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Td Bank Tower 66 Wellington Street West ...Phone Number
(858) 926-2730Website
www.aptose.comRevenue
-Stock Symbol
APSIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Aptose Biosciences
Aptose Biosciences is a clinical-stage biotechnology company focused on the development of targeted cancer therapies designed to address unmet medical needs in hematologic malignancies. The company is engaged in building a pipeline of innovative oncology treatments that aim to improve outcomes for patients with difficult-to-treat and treatment-resistant forms of cancer. Its scientific approach is centered on identifying key disease drivers in cancer cells and developing therapies that can selectively target these mechanisms.Explore more
Aptose Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptose Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aptose Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Aptose Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Aptose Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aptose Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aptose Biosciences
Check if Aptose Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Aptose Biosciences is spiking on competitors!
Product Launch: Get notified when Aptose Biosciences launches new products
Recommended Actions
Reach out to Masked Content who joined Aptose Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Aptose Biosciences
Compare insights from companies similar to Aptose Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aptose Biosciences
11-50
Public
-
1986
PL
Philippe LedruSenior Vice President - Chief Commercial Officer
Company Profile Activity
Activity Insights
Aptose Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aptose Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aptose Biosciences.
Aptose Biosciences Tech Stack
A closer look at the technologies used by Aptose Biosciences
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Event
Aptose Biosciences is conducting its annual and special meeting of shareholders virtually, offering registered shareholders and duly appointed proxy holders the opportunity to participate and vote electronically.
Events, Corporate Strategy
Executive Move
Executive Moves, Board of Directors
Project
Product Development, Medical Research, Pharmaceuticals
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptose Biosciences
Sign Up For FreeTo access detailed company insights
Aptose Biosciences is a clinical-stage biotechnology company focused on the development of targeted cancer therapies designed to address unmet medical needs in hematologic malignancies. The company is engaged in building a pipeline of innovative oncology treatments that aim to improve outcomes for patients with difficult-to-treat and treatment-resi... Read More
